Concepedia

Publication | Closed Access

Age-related efficacy of the selective ß3-adrenoceptor agonist mirabegron for the treatment of overactive bladder (OAB): pooled analysis of three prospective, randomised Phase III studies in patients aged >= 65 years

10

Citations

0

References

2012

Year

No additional data available for this publication yet. Check back later!